United States· US:0409-6482_129ba067-a214-45c6-8c39-cafc82a32546
Erythrocin Lactobionate
A medicinal product containing erythromycin lactobionate, registered in United States by Hospira, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERYTHROMYCIN LACTOBIONATE
- Manufacturer
- Hospira, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11040964820110 VIAL in 1 TRAY (0409-6482-01) / 10 mL in 1 VIAL (0409-6482-11)
- ndc110409-6482-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erythromycin lactobionate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomErythrocin IV lactobionate 1g powder for solution for infusion vialsAdvanz Pharma
- FinlandAbboticinOrifarm Oy
- GermanyErythrocin-I.V.Amdipharm Limited
- BelgiumErythrocine IV 1 gAmdipharm
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Erythrocin - Lactobionat
- Cyprus · Erythromycin I.V. Inresa
- Germany · Erythrocin-I.V., Erythromycin Inresa
- Spain · Pantomicina
- France · Erythrocine
- United Kingdom (Northern Ireland) · Erythrocin I.V. Lactobionate, Erythromycin Lactobionate Amdipharm Uk
- Ireland · Erythrocin Iv Lactobionate
- Italy · Eritromicina Lattobionato Fisiopharma
- Norway · Abboticin
- Portugal · Eritrocel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0511963e-3625-44e8-bd42-e0b6915e377c GET /v1/drugs/0511963e-3625-44e8-bd42-e0b6915e377c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "500",
"substance": "ERYTHROMYCIN LACTOBIONATE",
"productndc": "0409-6482",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/10mL",
"application_number": "NDA050609",
"marketing_category": "NDA"
}See everything about erythromycin lactobionate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.